Search for: "Dr Reddys Laboratories Inc"
Results 61 - 80
of 102
Sort by Relevance
|
Sort by Date
24 Aug 2011, 12:33 am
(BIOtechNOW) Matrix tablets and scope of protection: a reader asks (The SPC Blog) UK: Manual of Patent Practice revised to include guidelines for assessing obviousness of ‘selection inventions’ in light of Dr Reddy (IPKat) US: Strength in numbers? [read post]
27 Jul 2011, 1:01 am
Paddock Laboratories, Inc. [read post]
25 Apr 2011, 3:16 pm
Reddy's Laboratories (Dr. [read post]
3 Apr 2011, 10:21 pm
Reddy’s Laboratories, Inc’s June 2009 petition (Docket No. [read post]
12 Oct 2010, 8:56 pm
Apotex asks Supreme Court to review generic Cozaar/Hyzaar 180-day exclusivity decision (FDA Law Blog) Faslodex (Fulvestrant) – US: AstraZeneca seeks review of BPAI decision concerning patent covering ‘Use of Fulvestrant in treatment of resistant breast cancer’ (Patent Docs) Gemzar (Gemcitabine) – US: Eli Lilly files patent infringement complaint against Dr Reddy’s following Para IV certification (Patent Docs) Lipitor (Atorvastatin) – US: Generic… [read post]
9 Sep 2010, 7:09 pm
Dr. [read post]
30 Jun 2010, 5:52 am
Reddy's Laboratories, Ltd. et al. [read post]
29 Jun 2010, 6:01 pm
Reddy’s Laboratories, Ltd. et al. [read post]
23 Jun 2010, 10:28 pm
Reddy's over generic Allegra (Patent Docs) Combigan (Brimonidine) – US: Patent infringement complaint following a Para IV certification: Allergan, Inc. v. [read post]
16 Jun 2010, 5:51 am
Reddy's Laboratories, Ltd. et al., 2-09-cv-04638 (NJD June 14, 2010, Memorandum Opinion) (Brown, J.) [read post]
3 Jun 2010, 5:35 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/ Highlights this week included: US: Sen Kerry introduces Angiomax PTE amendment to Tax Extenders Act of 2009 (FDA Law Blog) General Nature Biotechnology and more anti-gene patenting myths (Patent Docs) Alice de Pastor’s SPC news 2009 (The SPC Blog) US: Sen Kerry introduces Angiomax PTE amendment to Tax Extenders Act of 2009 (FDA Law Blog) US: Blinded… [read post]
27 Apr 2010, 10:58 pm
(Patent Docs) Prilosec (Omeprazole) – US: Dr Reddy’s wins attorney’s fees from AstraZeneca in Prilosec OTC case (Orange Book Blog) Protonix (Pantoprazole) – US: Jury finds Protonix patent infringed by Teva (The IP Factor) Restasis (Ciclosporin) – Restasis royalty dispute finally settles (IP finance) Tarceva (Erlotinib) – India: Roche and Tarceva in Delhi HC again, this time vs Natco (Spicy IP) (Generic Pharmaceuticals and IP) Viagra (Sildenafil)… [read post]
7 Apr 2010, 4:30 am
Dr. [read post]
23 Dec 2009, 12:40 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Zyprexa (Olanzapine) – UK: Court of Appeal upholds Justice Floyd’s decision finding Olanzapine patent valid: Dr Reddy’s Laboratories v Eli Lilly (EPLAW) (IPKat) (Managing IP) (PatLit) (GenericsWeb) France: Pharma trade marks under threat - Senate and National Assembly approve law that… [read post]
18 Dec 2009, 9:59 am
Reddy's Laboratories Ltd. and Dr. [read post]
16 Dec 2009, 3:39 am
Reddy's Laboratories Ltd. et al. [read post]
8 Oct 2009, 6:05 am
Teva, Mylan, Dr. [read post]
27 Sep 2009, 2:30 pm
Teva and Myland and Dr. [read post]
6 Aug 2009, 9:16 pm
Reddy's Laboratories, Inc., citing Kingsdown Medical Consultants, Ltd. v. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
